UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study

Headache, 2016-09, Vol.56 (8), p.1317-1332

2016

Volltextzugriff (PDF)

Rotigotine improves restless legs syndrome: A 6-month randomized, double-blind, placebo-controlled trial in the United States

Movement disorders, 2010-08, Vol.25 (11), p.1675-1683

2010

Volltextzugriff (PDF)

Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine

Cephalalgia, 2018-02, Vol.38 (2), p.215-224

2018

Volltextzugriff (PDF)

Tramadol/Acetaminophen for the Treatment of Acute Migraine Pain: Findings of a Randomized, Placebo-Controlled Trial

Headache, 2005-11, Vol.45 (10), p.1317-1327

2005

Volltextzugriff (PDF)

Assessing the Ability of Topiramate to Improve the Daily Activities of Patients With Migraine

Mayo Clinic proceedings, 2006-10, Vol.81 (10), p.1311-1319

2006

Volltextzugriff (PDF)

Inheritance of Cluster Headache and its Possible Link to Migraine

Headache, 1994-07, Vol.34 (7), p.400-407

1994

Volltextzugriff (PDF)

Non-Invasive Vagus Nerve Stimulation for the AC ute T reatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study

Headache, 2016-09, Vol.56 (8), p.1317-1332

2016

Volltextzugriff (PDF)

Evaluation of Carisbamate for the Treatment of Migraine in a Randomized, Double-Blind Trial

Headache, 2009-02, Vol.49 (2), p.216-226

2009

Volltextzugriff (PDF)

Rapid and Sustained Relief of Migraine Attacks With Intranasal Lidocaine: Preliminary Findings

Headache, 1995-02, Vol.35 (2), p.79-82

1995

Volltextzugriff (PDF)

Research Submission: Tramadol-Acetaminophen for the Treatment of Acute Migraine Pain: Findings of a Randomized, Placebo-Controlled Trial

Headache, 2005-11, Vol.45 (10), p.1317-1327

2005

Volltextzugriff (PDF)

Intranasal Lidocaine

Headache, 1995-10, Vol.35 (9), p.565-566

1995

Volltextzugriff (PDF)

Successful Aspirin Prophylaxis in a Child with Chronic Paroxysmal Hemicrania

Headache, 1989-05, Vol.29 (5), p.280-281

1989

Volltextzugriff (PDF)

Association of Sustained Oxyhemoglobin Desaturation and Onset of Cluster Headache Attacks

Headache, 1990-07, Vol.30 (8), p.474-480

1990

Volltextzugriff (PDF)

The Role of Chemoreceptor Activity and Oxyhemoglobin Desaturation in Cluster Headache

Headache, 1993-10, Vol.33 (9), p.483-484

1993

Volltextzugriff (PDF)

Botulism associated with Clostridium botulinum sinusitis after intranasal cocaine abuse

Annals of internal medicine, 1988-12, Vol.109 (12), p.984

1988

Volltextzugriff (PDF)

Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial

Lancet neurology, 2014-11, Vol.13 (11), p.1100-1107

2014

Volltextzugriff (PDF)

Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy

Neurology, 2020-05, Vol.94 (20)

2020

Volltextzugriff (PDF)

Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2021-01, Vol.397 (10268), p.51-60

2021

Volltextzugriff (PDF)

Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine

Headache, 2020-09, Vol.60 (8), p.1734-1742

2020

Volltextzugriff (PDF)

A multicenter, open-label long-term safety study of rimegepant for the acute treatment of migraine

Cephalalgia, 2024-04, Vol.44 (4), p.3331024241232944-3331024241232944

2024

Volltextzugriff (PDF)

Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension

Cephalalgia, 2021-01, Vol.41 (1), p.6-16

2021

Volltextzugriff (PDF)

A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene‐related peptide ligand (galcanezumab) or receptor (erenumab) antagonist

Headache, 2022-10, Vol.62 (9), p.1164-1176

2022

Volltextzugriff (PDF)

Reduction in migraine pain intensity in patients treated with erenumab: A post hoc analysis of two pivotal randomized studies

Cephalalgia, 2021-12, Vol.41 (14), p.1458-1466

2021

Volltextzugriff (PDF)

Long‐term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis

Headache, 2023-06, Vol.63 (6), p.730-742

2023

Volltextzugriff (PDF)

Conversion to eslicarbazepine acetate monotherapy: A pooled analysis of 2 phase III studies

Neurology, 2016-03, Vol.86 (12), p.1095-1102

2016

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Headache
(16)
Cephalalgia
(4)
Headache: The Journal Of Head And Face Pain
(2)
Neurology
(2)
Annals Of Internal Medicine
(1)
Lancet Neurology
(1)
Mayo Clinic Proceedings
(1)
Movement Disorders
(1)
Pain Medicine
(1)
The Clinical Journal Of Pain
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study

Rotigotine improves restless legs syndrome: A 6-month randomized, double-blind, placebo-controlled trial in the United States

Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine

Tramadol/Acetaminophen for the Treatment of Acute Migraine Pain: Findings of a Randomized, Placebo-Controlled Trial

Assessing the Ability of Topiramate to Improve the Daily Activities of Patients With Migraine

Inheritance of Cluster Headache and its Possible Link to Migraine

Non-Invasive Vagus Nerve Stimulation for the AC ute T reatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study

Evaluation of Carisbamate for the Treatment of Migraine in a Randomized, Double-Blind Trial

Rapid and Sustained Relief of Migraine Attacks With Intranasal Lidocaine: Preliminary Findings

Research Submission: Tramadol-Acetaminophen for the Treatment of Acute Migraine Pain: Findings of a Randomized, Placebo-Controlled Trial

Intranasal Lidocaine

Successful Aspirin Prophylaxis in a Child with Chronic Paroxysmal Hemicrania

Association of Sustained Oxyhemoglobin Desaturation and Onset of Cluster Headache Attacks

The Role of Chemoreceptor Activity and Oxyhemoglobin Desaturation in Cluster Headache

Botulism associated with Clostridium botulinum sinusitis after intranasal cocaine abuse

Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial

Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy

Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial

Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine

A multicenter, open-label long-term safety study of rimegepant for the acute treatment of migraine

Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension

A phase IV clinical trial of gastrointestinal motility in adult patients with migraine before and after initiation of a calcitonin gene‐related peptide ligand (galcanezumab) or receptor (erenumab) antagonist

Reduction in migraine pain intensity in patients treated with erenumab: A post hoc analysis of two pivotal randomized studies

Long‐term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis

Conversion to eslicarbazepine acetate monotherapy: A pooled analysis of 2 phase III studies

Suchergebnisse filtern